Neurosteer received the “Brain Health Company of the Year” award from Tradex News. It has been a great year for us, most notably in improving our product for early screening of Alzheimer’s, Parkinson’s and frontotemporal dementia. Looking forward to 2020 with FDA clearance, early marketing, and extended clinical trials.
Following recent fMRI studies on the effect of music on the brain, Israeli TV Channel 13 interviewed Neta Maimon, a PhD student in music cognition at Tel Aviv University and a researcher at Neurosteer. Using Neurosteer sensing technology on a group of brain-monitored study participants, emotional and cognitive responses to songs were clearly visible.
Neurosteer monitored two runners, in real time, during the NYC marathon on Nov 3rd. Prof. Steven Laureys, a key figure in the European Human Brain Project, was behind this initiative, which created significant interest in sports and other brain monitoring in extreme physical conditions. The article in DeMorgen describes it (in Dutch; use Google Translate). The full event was streamed live on Facebook. When going over the recording, one can see that Steven was meditating during much of the run (a well-known method to reduce oxygen consumption).
Neurosteer, together with Stanford Prof. Carla Pugh, is quantifying and assessing surgeon performance before and during surgery as part of the Stanford Surgical Metrics project. During the American College of Surgeons conference in San Fransisco, brain activity data from more than 200 surgeons was collected. Check out the video to see the cognitive assessment and monitoring during simulated surgery. This illustrates an application of Neurosteer’s platform for the evaluation of cognitive performance of healthy subjects. The same setup can be used to monitor pilots and others during critical missions.
Matthieu Ricard is one of the Buddhist monks that is most studied by Neuroscientists. His compassion meditation was contrasted with Indian breathing and mindfulness meditations by leading researchers. Matthieu joined Professor Steven Laureys for meditation and dialogue. Neurosteer monitored the brain activity during his compassion meditation, which looks very different from other meditations. We are excited to see a shift from multiple electrodes and fMRI to our single EEG channel.
The Parkinson Therapy Center in Brescia attracts patients from all over the world (many under 60) for a week of training to live with the disease. The neuropsychologists at the center are using Neurosteer’s frontal lobe cognitive assessment to suggest specific therapies to the different patients. Here is a short broadcast demonstrating this exciting project on Italian television.
The machine is used by the European Parkinson Therapy Centre.
Neurosteer started a clinical study at Langone Hospital, NYU with Prof. Leigh Charvet, on quantifying the effect of tDCS on Multiple Sclerosis (MS) patients. MS patients receive a frontal lobe stimulation to improve their cognition. Such stimulation is not always effective, and often patients receive 20 stimulation sessions to discover at the end that there was no effect. Neurosteer’s device will assess the effectiveness of the stimulation after one session and this will be correlated with the effect after 20 sessions. Such an assessment can provide an indication of the effectiveness of the treatment.